Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database
Article in Frontiers in Immunology (September 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database
Article in Frontiers in Pharmacology (August 2024)
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
Article in Frontiers in Pharmacology (July 2024)